1Arciola CR, Campoccia D, An YH, et al. Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants[J]. Int J Artif Organs, 2006,29 : 395-401.
4Joseph FJ, Alexander MH, Ralph HJ. History and evolution of antibiotic resistance in coagulase-negative staphylococei: susceptibility profiles of new anti-staphylococcal agents[J]. Ther Clin Risk Manag,2007,3(6) :1143-1152.
5Gaudioso de Allori MC, Jure MA, Romero C, et al. Antimi crobial resistance and production of biofilms in clinical isolates of coagulase-negative staphylococcus strains[J]. Biol Pharm Bull, 2006,29 : 1592-1596.
6Widerstrom M, Monsen T, Karlsson C, et al. Molecular epidemiology of methicillin resistant coagulase-negative staphylococci in a Swedish county hospital:evidence of intra and interhospital clonal spread[J]. J Hosp Infect, 2006,64: 177-183.
7Cerca N, Martins S, Cerca F, et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry[J]. J Antimicrob Chemother, 2005,56 : 331-336.
8Stryjewski ME, Chu VH, O' Riorday WD, et al. Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by Gram positive bacteria: FAST study[J]. Antimicrob Agents Chemother, 2006, 50: 862-867.
9Fritsche TR, Rennie RP, Coldstein BP, et al. Comparison of dalbavancin MIC values determined by Etest (AB Biodisk) and reference dilution methods using Gram positive organisms[J]. J Clin Microbiol,2006,44:2988-2990.
10Pankuch GA, Appelbaum PC. Postantibiotic effect of ceftibiprole against 12 Gram-positive organisms[J]. Antimicrob Agents Chemother, 2006,50:3956-3958.
